The t(10;11)(p13;q14) in the U937 Cell Line Results in the Fusion of the AF10 Gene and CALM, Encoding a New Member of the AP-3 Clathrin Assembly Protein Family

Autor: Dreyling, M. H., Martinez-Climent, J. A., Zheng, M., Mao, J., Rowley, J. D., Bohlander, S. K.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America, 1996 May . 93(10), 4804-4809.

Externí odkaz: https://www.jstor.org/stable/38857

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative.

Autor: Corboy G; LabPlus, Auckland City Hospital, Grafton, New Zealand; Department of Molecular Medicine and Pathology, The University of Auckland, Grafton, New Zealand; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia. Electronic address: gregc@adhb.govt.nz., Othman J; Department of Haematology, Royal North Shore Hospital, St Leonards, NSW, Australia., Lee L; Molecular Haematology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia., Wei A; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Department of Haematology, Alfred Health, Prahran, Vic, Australia., Ivey A; Department of Pathology, Alfred Health, Prahran, Vic, Australia., Blombery P; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Peter MacCallum Cancer Centre, Parkville, Vic, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Vic, Australia., Agarwal R; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Department of Haematology, Austin Health, Heidelberg, Vic, Australia., Fong C; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Department of Haematology, Austin Health, Heidelberg, Vic, Australia., Brown A; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA, Australia; ACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia., Scott H; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia; Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA, Australia; ACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia., Grove C; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; PathWest Laboratory Medicine, Perth, WA, Australia; Sir Charles Gairdner Hospital, Perth, WA, Australia., Louw A; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; PathWest Laboratory Medicine, Perth, WA, Australia., Enjeti A; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Department of Haematology and Molecular Medicine, NSW Health Pathology - Hunter, John Hunter Hospital, Newcastle, NSW, Australia., Iland H; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Department of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Paul C; Department of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Bohlander S; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, Grafton, New Zealand., Kakadia P; Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, Grafton, New Zealand., Horan M; Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP), St Leonards, NSW, Australia., Stevenson W; Australasian Leukaemia and Lymphoma Group (ALLG), Richmond, Vic, Australia; Department of Haematology, Royal North Shore Hospital, St Leonards, NSW, Australia; Molecular Haematology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia.

Publikováno v: Pathology [Pathology] 2021 Jun; Vol. 53 (4), pp. 487-492. Date of Electronic Publication: 2020 Dec 04.

AML1–ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia.

Autor: Schneider, F.¹, Bohlander, S. K.^1,2, Schneider, S.¹, Papadaki, C.^1,2, Kakadyia, P.^1,2, Dufour, A.¹, Vempati, S.², Unterhalt, M.¹, Feuring-Buske, M.^1,2, Buske, C.^1,2, Braess, J.^1,2, Wandt, H.³, Hiddemann, W.^1,2, Spiekermann, K.^1,2 karsten.spiekermann@med.uni-muenchen.de

Publikováno v: Leukemia (08876924). Oct2007, Vol. 21 Issue 10, p2199-2201. 3p. 2 Black and White Photographs, 1 Graph.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.